Screener
RPC
Radient Pharmaceuticals Corporation
RPCRadient Pharmaceuticals Corporation is a investment - banking & investment services company in the financial services sector trading on XASE, led by CEO Luke A. Sarsfield, with a market cap of $948.7M.
$948.68M+12.4%
We’re still putting together Radient Pharmaceuticals Corporation’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.
Ask us to move Radient Pharmaceuticals Corporation up the queue, and we’ll analyze its filings next.
Earnings
Next report
Aug 5, 2026 (Tomorrow)Revenue estimate$80.8M
EPS estimate$0.23
Profile
CountryUnited States of America
Listed2021
CEOLuke A. Sarsfield
SectorFinancial Services
Websiteridgepostcapital.com
FilingsSEC EDGAR